ZyVersa Therapeutics, Inc. (ZVSA)
OTCMKTS · Delayed Price · Currency is USD
0.1430
-0.0416 (-22.54%)
At close: Jul 18, 2025
ZyVersa Therapeutics Market Cap
ZyVersa Therapeutics has a market cap or net worth of $696.91 thousand as of July 18, 2025. Its market cap has decreased by -76.35% in one year.
Market Cap
696.91K
Enterprise Value
-914.63K
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.14
Market Cap Chart
Since February 10, 2022, ZyVersa Therapeutics's market cap has decreased from 95.47M to 696.91K, a decrease of -99.27%. That is a compound annual growth rate of -76.12%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 18, 2025 | 696.91K | -73.79% |
Dec 31, 2024 | 2.66M | -43.66% |
Dec 29, 2023 | 4.72M | -66.90% |
Dec 30, 2022 | 14.26M | -85.07% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Endo, Inc. | 1.61B |
Veradigm | 832.17M |
Nika Pharmaceuticals | 708.22M |
Tian'an Technology Group | 628.15M |
Elite Pharmaceuticals | 599.09M |
Glass House Brands | 434.24M |
CytoDyn | 394.89M |
Northwest Biotherapeutics | 382.15M |